Price $265.35 |
Market Cap
179.79B
|
Sector Health Care |
Div. Growth
17.90%
|
|
P/E
27.3
|
P/B
3.97
|
P/S
5.76
|
Dividend %
0.40%
|
|
P/CF
70.1
|
P/FCF
29.1
|
Op. Cash Flow
8.31M
|
FCF
8.4
|
|
Op. Margin
27.00%
|
Net Margin
21.20%
|
ROE
15.20%
|
ROI
9.60%
|
|
ROA
8.10%
|
EPS Growth
14.80%
|
Current Ratio
1.4
|
Debt/Equity
52.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.56 | - | - | 71.5M | Strong Buy |
| LogicMark Inc (LGMK) | $0.69 | - | - | 7.3M | Strong Buy |
| LivaNova PLC (LIVN) | $54.01 | - | - | 2.56B | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $2.86 | - | - | 12.9M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.57 | - | - | 19.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
